Lexicon Pharmaceuticals Inc banner

Lexicon Pharmaceuticals Inc
NASDAQ:LXRX

Watchlist Manager
Lexicon Pharmaceuticals Inc Logo
Lexicon Pharmaceuticals Inc
NASDAQ:LXRX
Watchlist
Price: 1.5 USD Market Closed
Market Cap: $545.1m

Wall Street
Price Targets

LXRX Price Targets Summary
Lexicon Pharmaceuticals Inc

Wall Street analysts forecast LXRX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for LXRX is 2.98 USD with a low forecast of 1.01 USD and a high forecast of 6.3 USD.

Lowest
Price Target
1.01 USD
33% Downside
Average
Price Target
2.98 USD
99% Upside
Highest
Price Target
6.3 USD
320% Upside
Lexicon Pharmaceuticals Inc Competitors:
Price Targets
ONDS
Ondas Holdings Inc
88% Upside
IPAR
Inter Parfums Inc
9% Upside
MEDP
Medpace Holdings Inc
10% Upside
QNST
Quinstreet Inc
80% Upside

Revenue
Forecast

25% / Year
Past Growth
19% / Year
Estimated Growth
Estimates Accuracy
0%
Average Beat
25% / Year
Past Growth
19% / Year
Estimated Growth
Estimates Accuracy
0%
Average Beat

For the last 13 years the compound annual growth rate for Lexicon Pharmaceuticals Inc's revenue is 25%. The projected CAGR for the next 4 years is 19%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-5%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-5%
Average Miss

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-77%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-77%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is LXRX's stock price target?
Price Target
2.98 USD

According to Wall Street analysts, the average 1-year price target for LXRX is 2.98 USD with a low forecast of 1.01 USD and a high forecast of 6.3 USD.

What is Lexicon Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
19%

For the last 13 years the compound annual growth rate for Lexicon Pharmaceuticals Inc's revenue is 25%. The projected CAGR for the next 4 years is 19%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett